Description
KLOW is a proprietary research blend combining four well-characterized peptides: GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg). Preclinical research has examined GHK-Cu’s role in tissue remodeling, BPC-157’s effects in repair and angiogenesis models, TB-500’s actin dynamics and cell migration properties, and KPV’s studied influence on NF-κB signaling and inflammatory mediator expression. This combination is formulated for researchers studying multi-pathway tissue repair and inflammatory biology.
Supplied as: Lyophilized powder, sealed vial (GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg)
Purity: ≥99% per component (HPLC verified)
Testing: Third-party mass spectrometry and HPLC per batch
Storage: −20°C, away from light and moisture
Reconstitution: Bacteriostatic water (not included)
For research use only. Not for human or animal administration. Must be handled by a qualified researcher in a licensed laboratory setting. Not approved by the FDA and not intended for diagnostic or therapeutic use.










